Drug Shortage Report for LORAZEPAM
| Report ID | 17964 |
| Drug Identification Number | 02351072 |
| Brand name | LORAZEPAM |
| Common or Proper name | LORAZEPAM TAB |
| Company Name | SANIS HEALTH INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LORAZEPAM |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-11-03 |
| Estimated end date | |
| Actual end date | 2018-01-11 |
| Shortage status | Resolved |
| Updated date | 2020-02-27 |
| Company comments | Business decision made to discontinue product. See Discontinuation Report # 107347 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-02-27 | French | Compare |
| v3 | 2020-02-27 | English | Compare |
| v2 | 2017-08-02 | French | Compare |
| v1 | 2017-08-02 | English | Compare |
Showing 1 to 4 of 4